Oncology

Atezolizumab demonstrated significant improvement in survival compared with docetaxel in individuals with non-small cell lung cancer.

Premenopausal, overweight women have a decreased risk of breast cancer, while postmenopausal women have an increased risk.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

With the high number of oral therapies hitting the market, specialty pharmacies are now on the frontline of cancer treatment.

A general lack of knowledge for symptoms of cancer linked to regions where cancer survival is worse.

Novartis presented results from clinical trials of Zykadia at the European Society of Medical Oncology Congress.

Crizotinib-pre-treated patients with non-small cell lung cancer experienced superior survival rates compared with chemotherapy.

Adjuvant treatment with recombinant, human monoclonal antibody extended overall survival in patients with melanoma in a recent trial.

Top news of the day from across the health care landscape.

LEE011 plus letrozole may prove to be effective first-line breast cancer therapy.

LEE011 plus letrozole demonstrates significant progression free survival in patients with breast cancer.

Researchers discover which type of gut bacteria may influence the effectiveness of chemotherapy.

Top news of the week in oncology, and cancer drug development.

FDA grants Roche’s drug Alecensa another Breakthrough Therapy Designation.

Alecensa found to increase progression-free survival in ALK-positive non-small cell lung cancer compared with crizotinib.

Natural killer cells ‘trained’ to more effectively attack cancer cells in patients with AML.

The combined use of radiation therapy and a neutrophil stimulant can increase anti-tumor immunity.

New insights into a gene with anti-cancer activity may grow options for cancer treatment.

A new report updates medical community on primary sclerosing cholangitis.

Top news of the day from across the health care landscape.

Enzyme found to promote immune suppression by blocking the activation of anti-tumor T cells.

Top news of the day from across the healthcare landscape.

A 7-year study identified genetic pathways hijacked by cancer stem cells to promote tumor growth.

Device shows promise preventing cancer cells from migrating to other organs in the body.

Top news of the day from across the health care landscape.

Shutting off a critical enzyme in lipid synthesis found to stifle tumor growth.

A potential mechanism for the early detection of gastric cancer may lead to better treatment and prognosis.